Androgenetic alopecia treated with topical minoxidil

Area of Science:

• Dermatology
• Pharmacology

Background:

• Male pattern baldness is a common condition affecting numerous individuals.
• Current treatments for androgenetic alopecia have varying efficacy and side effect profiles.

Purpose of the Study:

• To evaluate the efficacy of topical minoxidil solutions at different concentrations (2% and 3%) in treating male pattern baldness.
• To compare the effects of minoxidil with a placebo over a 12-month period.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted over 12 months.
• 56 male patients with pattern baldness were assigned to receive either 2% minoxidil, 3% minoxidil, or placebo.
• The placebo group transitioned to 3% minoxidil after 4 months.

Main Results:

• Both 2% and 3% topical minoxidil solutions demonstrated a significant increase in terminal and indeterminate hair counts compared to placebo at 4 months (p < 0.05).
• Over 12 months, a decrease in vellus hair count was observed, with a concurrent increase in indeterminate and terminal hair counts.
• Topical minoxidil application showed a partial reversal of the balding phenomenon.

Conclusions:

• Topical minoxidil, at both 2% and 3% concentrations, is effective in promoting hair regrowth in male pattern baldness.
• The study suggests minoxidil's potential to counteract the effects of androgenetic alopecia by influencing hair follicle dynamics.